In renal cell carcinoma (RCC), tumor-infiltrating CD4+ T cells were found to predominantly express both CCR5 and CXCR3, supporting a Th1-polarized immune infiltrate. This evidence concerns the gene CXCR3 and renal cell carcinoma.